Walczak H - Search Results

1

Zinngrebe J, Montinaro A, Peltzer N, Walczak H. Zinngrebe J, et al. Among authors: walczak h. EMBO Rep. 2014 Jan;15(1):28-45. doi: 10.1002/embr.201338025. Epub 2013 Dec 27. EMBO Rep. 2014. PMID: 24375678 Free PMC article. Review.

2

TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer.

Walczak H. Walczak H. Immunol Rev. 2011 Nov;244(1):9-28. doi: 10.1111/j.1600-065X.2011.01066.x. Immunol Rev. 2011. PMID: 22017428 Review.

3

Generation and physiological roles of linear ubiquitin chains.

Walczak H, Iwai K, Dikic I. Walczak H, et al. BMC Biol. 2012 Mar 15;10:23. doi: 10.1186/1741-7007-10-23. BMC Biol. 2012. PMID: 22420778 Free PMC article. Review.

4

Linear ubiquitination: a newly discovered regulator of cell signalling.

Rieser E, Cordier SM, Walczak H. Rieser E, et al. Among authors: walczak h. Trends Biochem Sci. 2013 Feb;38(2):94-102. doi: 10.1016/j.tibs.2012.11.007. Epub 2013 Jan 17. Trends Biochem Sci. 2013. PMID: 23333406 Review.

5

IL-24 sensitizes tumor cells to TLR3-mediated apoptosis.

Weiss R, Sachet M, Zinngrebe J, Aschacher T, Krainer M, Hegedus B, Walczak H, Bergmann M. Weiss R, et al. Among authors: walczak h. Cell Death Differ. 2013 Jun;20(6):823-33. doi: 10.1038/cdd.2013.15. Epub 2013 Mar 1. Cell Death Differ. 2013. PMID: 23449395 Free PMC article.

6

Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1.

Lemke J, von Karstedt S, Abd El Hay M, Conti A, Arce F, Montinaro A, Papenfuss K, El-Bahrawy MA, Walczak H. Lemke J, et al. Among authors: walczak h. Cell Death Differ. 2014 Mar;21(3):491-502. doi: 10.1038/cdd.2013.179. Epub 2013 Dec 20. Cell Death Differ. 2014. PMID: 24362439 Free PMC article.

7

The seven wonders of ubiquitin: a multi-interview: Personal insights into the ubiquitin field. Interview by Nonia Pariente.

Dikic I, Harper W, Hay R, Langer T, Rape M, Sixma T, Walczak H. Dikic I, et al. Among authors: walczak h. EMBO Rep. 2014 Jan;15(1):7-11. doi: 10.1002/embr.201338230. EMBO Rep. 2014. PMID: 24398128 Free PMC article. No abstract available.

8

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells.

Tuthill MH, Montinaro A, Zinngrebe J, Prieske K, Draber P, Prieske S, Newsom-Davis T, von Karstedt S, Graves J, Walczak H. Tuthill MH, et al. Among authors: walczak h. Oncogene. 2015 Apr 16;34(16):2138-2144. doi: 10.1038/onc.2014.156. Epub 2014 Jun 9. Oncogene. 2015. PMID: 24909167 Free PMC article.

9

Getting TRAIL back on track for cancer therapy.

Lemke J, von Karstedt S, Zinngrebe J, Walczak H. Lemke J, et al. Among authors: walczak h. Cell Death Differ. 2014 Sep;21(9):1350-64. doi: 10.1038/cdd.2014.81. Epub 2014 Jun 20. Cell Death Differ. 2014. PMID: 24948009 Free PMC article. Review.

10

HOIP deficiency causes embryonic lethality by aberrant TNFR1-mediated endothelial cell death.

Peltzer N, Rieser E, Taraborrelli L, Draber P, Darding M, Pernaute B, Shimizu Y, Sarr A, Draberova H, Montinaro A, Martinez-Barbera JP, Silke J, Rodriguez TA, Walczak H. Peltzer N, et al. Among authors: walczak h. Cell Rep. 2014 Oct 9;9(1):153-165. doi: 10.1016/j.celrep.2014.08.066. Epub 2014 Oct 2. Cell Rep. 2014. PMID: 25284787 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page